FDA Approves Dupixent as First New Targeted CSU Therapy in Over a Decade
FDA Approves Dupixent as First New Targeted CSU Therapy in Over a Decade Chronic spontaneous urticaria, sometimes referred to as chronic idiopathic urticaria, is a condition characterized by the spontaneous…
UK MHRA Approves Blenrep Combos for Relapsed/Refractory Multiple Myeloma
UK MHRA Approves Blenrep Combos for Relapsed/Refractory Multiple Myeloma GSK plc has achieved a critical regulatory milestone with the Medicines and Healthcare products Regulatory Agency (MHRA) granting authorisation for expanded…
6 Key Ways Pharmacists Contribute to Your Health and Wellbeing
6 Key Ways Pharmacists Contribute to Your Health and Wellbeing When it comes to managing your health in a fast-paced world, access to reliable, professional healthcare can make all the…
Feinstein Researchers Lead Breakthrough Study for Lupus Kidney Disease
Feinstein Researchers Lead Breakthrough Study for Lupus Kidney Disease In a significant breakthrough for autoimmune disease treatment, researchers at Northwell Health’s Feinstein Institutes for Medical Research have reported encouraging results…
Africa CDC and WHO Revise Mpox Strategy Amid Ongoing Outbreaks
Africa CDC and WHO Revise Mpox Strategy Amid Ongoing Outbreaks In a significant development aimed at containing the ongoing mpox outbreak, the Africa Centres for Disease Control and Prevention (Africa…
Cytokinetics Announces Equity Awards Granted Under Nasdaq Listing Rule 5635(c)(4)
Cytokinetics Announces Equity Awards Granted Under Nasdaq Listing Rule 5635(c)(4) Cytokinetics, Incorporated has taken another strategic step in fostering long-term company growth through a robust talent acquisition strategy that includes…
Kairos Pharma Wins DoD Grant to Study ENV105 for Drug-Resistant Lung Cancer
Kairos Pharma Wins DoD Grant to Study ENV105 for Drug-Resistant Lung Cancer Kairos Pharma, Ltd. , a clinical-stage biopharmaceutical company focused on developing novel cancer therapies, has announced a major…
EnPlusOne Biosciences Welcomes New CEO, Clare Murray, Ph.D.
EnPlusOne Biosciences Welcomes New CEO, Clare Murray, Ph.D. EnPlusOne Biosciences, Inc., a trailblazing biotechnology company pioneering enzyme-driven RNA synthesis technologies, announced today the appointment of Clare Murray, Ph.D., as its…
Bruker Launches nVista 2P: A New Generation of Miniature Two-Photon Microscopes
Bruker Launches nVista 2P: A New Generation of Miniature Two-Photon Microscopes Bruker Corporation a global leader in scientific instruments and imaging technologies, has announced the launch of the nVista 2P,…
PharmaJet Highlights Partner Data Showing Enhanced Immune Response with Needle-Free Vaccine Delivery
PharmaJet Highlights Partner Data Showing Enhanced Immune Response with Needle-Free Vaccine Delivery PharmaJet, a medical technology company pioneering innovative approaches to injectable drug delivery, will unveil compelling new data from…
Rigaku Partners with Spera Pharma to Advance Drug Development
Rigaku Partners with Spera Pharma to Advance Drug Development In a move poised to reshape the landscape of drug discovery and pharmaceutical development, Rigaku Corporation—a leading scientific instrumentation manufacturer—and SPERA…
Glycomine Raises $115M Series C to Advance GLM101 into Phase 2b Trial for PMM2-CDG
Glycomine Raises $115M Series C to Advance GLM101 into Phase 2b Trial for PMM2-CDG Glycomine, Inc., a clinical-stage biotechnology company dedicated to developing life-changing therapies for patients suffering from orphan…